EquityZen Growth Technology Fund LLC - Series 161
Raised
$594K
Investors
27
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 161 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC, raising $594K from 27 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This amended filing, dated December 2017, is part of the EquityZen platform's pre-IPO secondary marketplace comprising nearly 1,900 related entities.
This pre-IPO fund follows the standard EquityZen platform structure: individual series LLCs providing retail-accessible ($10K minimum) exposure to private company secondary shares via 506(b) private placements. The 3(c)(1) exemption limits each series to 100 beneficial owners, consistent with the 27-investor count reported here.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
